Tagged with Pharmamar

Spain Pharma News Roundup: Layoffs at Grifols; PharmaMar Lung Cancer Approval; Esteve Inhaled Parkinson’s Treatment

Spain Spain Pharma News Roundup: Layoffs at Grifols; PharmaMar Lung Cancer Approval; Esteve Inhaled Parkinson’s Treatment

Spain A roundup of the latest news from Spanish pharma, including Almirall’s earnings forecast for 2023; stock price rise and layoffs at Grifols; PharmaMar’s first European approval for its lurbinectedin treatment of metastatic Small Cell Lung Cancer and Esteve’s launch of the first inhaled rescue treatment for Parkinson’s patients. Spain’s…

Spain Pharma News Roundup September 2020

Roundup Spain Pharma News Roundup September 2020

Roundup A roundup of the latest news from Spanish pharma, including J&J’s COVID-19 vaccine trial, the latest developments at Spanish firm PharmaMar which hopes its Aplidin can be used as a treatment for COVID-19, and a new biologics plant for contract manufacturer LSNE in the city of León. Johnson &…

Spain’s PharmaMar to Begin COVID-19 Trials for Aplidin

Spain Spain’s PharmaMar to Begin COVID-19 Trials for Aplidin

Spain PharmaMar, a Spanish firm, is beginning Phase II clinical trials for its anti-tumour drug Aplidin to treat coronavirus. The firm’s stocks have soared on the news. PharmaMar is joining the race to find a treatment for COVID1-9. The Madrid-based company that developed multiple myeloma therapy Aplidin (plitidepsin) announced that…

Interview: Mario Huber – General Manager, PharmaMar Austria

Austria Interview: Mario Huber – General Manager, PharmaMar Austria

Austria Mario Huber, general manager of PharmaMar Austria, a multinational and an innovative oncology-based Spanish company, discusses the growth of the company in Austria and the reasons behind the success of Yondelis®, the company’s flagship product. Furthermore, he provides an overview of the clinical trials the Austrian affiliate is undertaking and…

Austria: Nucleus of Clinical Trials

Austria Austria: Nucleus of Clinical Trials

Austria Like a family recipe that has been refined and perfected over countless generations, Austria has developed a reputation as the quintessential clinical trials destination; a perfect combination of world-class academia, willing volunteers and educated medical personnel balanced against a backdrop of economic stability. “Austria should be proud of the abundance…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page